Noteworthy Insider Buying and Selling at MiMedx Group, Aetna & Others

This Plummeting Biopharmaceutical Company’s CEO Bought Some Shares This Week

The co-founder, President and Chief Executive Officer of Concert Pharmaceuticals Inc. (NASDAQ:CNCE), Roger D. Tung, snapped up 19,610 shares on Wednesday for $10.55 each, boosting his direct ownership stake to 538,965 shares. Dr. Tung also owns 121,873 shares indirectly through the Roger D. Tung 2011 GRAT, as well as 13,274 shares and 12,389 shares through the Tung Family Investment Trust and RD Tung Irrevocable Trust, respectively.

Follow Concert Pharmaceuticals Inc. (NYSE:CNCE)

Concert Pharmaceuticals Inc. (NASDAQ:CNCE) is a clinical-stage biopharmaceutical company that focuses on applying its knowledge of deuterium chemistry to discover and develop novel small molecule drugs. To be more detailed, the company believes that certain already-approved drugs or advanced clinical candidates can be improved with deuterium substitution to offer better pharmacokinetic or metabolic properties. Concert shares have plummeted 46% since the start of 2016, partly owing to the release of the company’s business highlights, upcoming milestones and financial results for the first quarter. Ken Fisher’s Fisher Asset Management owns 55,934 shares of Concert Pharmaceuticals Inc. (NASDAQ:CNCE as of March 31.

A BDC’s Chairman Made a String of Securities Purchases This Week

John P. Bolduc, Chairman of WhiteHorse Finance Inc. (NASDAQ:WHF)’s Board of Directors, purchased 5,100 shares on Tuesday, 2,264 shares on Wednesday and 9,866 shares on Thursday at prices that ranged from $10.20 to $10.53 per share. After the recent purchases, the Chairman currently owns a stake of 174,376 shares.

Follow Whitehorse Finance Inc. (ASX:WHF)

WhiteHorse Finance Inc. (NASDAQ:WHF) operates as a business development company (BDC) that originates and invests in senior secured loans to performing small-cap companies across a variety of industries. The BDC’s investment portfolio had a fair value of $417.2 million at the end of March, up from $415.3 million at the end of December. The portfolio consisted of 38 positions across 31 companies with a weighted average effective yield of 11.9%. WhiteHorse Finance made a first-quarter distribution of $0.355 per share, which equates to an annual dividend yield of 13.71%. The shares of the BDC are 9% in the red year-to-date. Israel Englander’s Millennium Management had 33,381 shares of WhiteHorse Finance Inc. (NASDAQ:WHF) in its equity portfolio at the end of December.